Lisa C. McClain· SellGSK
Oct 31, 2025 · $1,001 to $15,000
Receipt-backed STOCK Act disclosure
As of August 18 at 4:57 AM EDT
Buy · Apr 9, 2021
Virginia Foxx bought GSK.
GSK. This page identifies a public filing and does not imply motive, causation, or wrongdoing.
Amount range
Receipt pending ingestion
Owner
Owner pending receipt parsing
Filed
May 5, 2021
Filing delay
26 days · within the 45-day window
Receipt
Official filing 20018670
Same-window market context
Comparable GSK and SPY closes are not available on identical dates for this transaction window.
Related activity
Receipt-qualified trades in the same tickers by other congressional filers.
Lisa C. McClain· BuyGSK
Oct 30, 2025 · $1,001 to $15,000
Lisa C. McClain· SellGSK
Oct 30, 2025 · $1,001 to $15,000
Valerie Hoyle· SellGSK
Sep 23, 2025 · $1,001 to $15,000
Lisa Mcclain· BuyGSK
Aug 4, 2025 · $1,001 to $15,000
Robert B. Aderholt· SellGSK
Jul 28, 2025 · $1,001 to $15,000
Get the weekly congress trading digest
One source-linked summary each week. Confirm by email; unsubscribe anytime.
Official receipt
Rendered from the official Clerk filing through Veridion's receipt-safe viewer.